Home
MAPRx Releases Report Examining 15 Years of Medicare Part D
Study Finds Popular Prescription Drug Benefit Program Faces Challenges
A new report released today on Medicare Part D found the program is as popular and robust as ever, but faces challenges that could result in increased costs and limited access for millions of beneficiaries. The study, “Fifteen Years of Part D: Gaining Perspective on the Medicare... Read more
MAPRx Coalition Comments to the CMS RFI Blueprint
The MAPRx Coalition sent a comment letter to Department of Health and Human Services Secretary Alex Azar responding to questions raised in the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. To view the letter, click here: MAPRx Coalition Comments to CMS RFI Blueprint 7.16.18... Read more
2018 Medicare Prescription Drug Annual Open Enrollment
The Annual Open Enrollment for Medicare prescription drug coverage (Part D)
is October 15, 2017 – December 7, 2017.
For more information, click here: MAPRx Open Enrollment Brochure 2018... Read more
MAPRx Coalition Calls on Congress to Reject Increased Copays for Medicare Part D Low Income Subsidy Beneficiaries
MAPRx Coalition Calls on Congress to Reject Increased Copays for Medicare Part D Low Income Subsidy Beneficiaries
On September 29, 2017, the MAPRx Coalition sent this letter urging Congress to reject any proposal to increase Medicare Part D copayments for beneficiaries receiving the low-income subsidy (LIS). The letters were addressed to the Chairs and Ranking Members of the Senate Committee on Finance... Read more
MAPRx Responds to CMS’s Advance Notice of Methodological Changes to Medicare Part D for Calendar Year (CY) 2018
March 2017 MAPRx CMS Comment Letter about Proposed Medicare Changes for CY 2018
The MAPRx Coalition raised concerns about the proposed changes to the Medicare prescription drug benefit program, which CMS issued in a "Draft Call Letter" on February 1, 2017. The draft letter included proposed changes for MA Capitation Rates, Part C and Part D Payment Policies, and the 2018 Call Letter.... Read more